Determination of Trace Levels of Lead in Whole Blood by Graphite Furnace Atomic Absorption Spectroscopy by Sombers, Leslie A.
W&M ScholarWorks 
Dissertations, Theses, and Masters Projects Theses, Dissertations, & Master Projects 
1998 
Determination of Trace Levels of Lead in Whole Blood by Graphite 
Furnace Atomic Absorption Spectroscopy 
Leslie A. Sombers 
College of William & Mary - Arts & Sciences 
Follow this and additional works at: https://scholarworks.wm.edu/etd 
 Part of the Analytical Chemistry Commons, and the Biochemistry Commons 
Recommended Citation 
Sombers, Leslie A., "Determination of Trace Levels of Lead in Whole Blood by Graphite Furnace Atomic 
Absorption Spectroscopy" (1998). Dissertations, Theses, and Masters Projects. Paper 1539626166. 
https://dx.doi.org/doi:10.21220/s2-52tb-6s33 
This Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M 
ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 
DETERMINATION OF TRACE LEVELS OF LEAD IN WHOLE BLOOD BY
GRAPHITE FURNACE 
ATOMIC ABSORPTION SPECTROSCOPY
A Thesis 
Presented to 
The Faculty of the Department of Chemistry 
The College of William and Mary in Virginia
In Partial Fulfillment 
O f the Requirements for the Degree of 
Master o f Arts
by
Leslie A. Sombers 
1998
APPROVAL SHEET
This thesis is submitted in partial fulfillment o f the requirements for the degree o f
Master o f Arts
lie/A. Sombers
Approved, August 1998
RiceDr.
Dr. Christopher Abeit
Dr. William Starnes
ii
Dedication
This thesis is dedicated to my mother and father. They have given me the gifts of 
hope, persistence and optimism, and the strength to follow my dreams.
TABLE OF CONTENTS
Page
ACKNOWLEDGEMENTS v
LIST OF TABLES vi
LIST OF FIGURES vii
ABSTRACT x
CHAPTER I: INTRODUCTION 2
LEAD IN THE ENVIRONMENT 2
COMPARISON OF SPECTROSCOPIC ANALYTICAL METHODS 4
CHAPTER II: GRAPHITE FURNACE ATOMIC ABSORPTION 8
SPECTROSCOPY
INTRODUCTION 8
INSTRUMENTATION 10
INTERFERENCES 17
OPTIMIZATION OF ANALYTICAL METHODS 20
CHAPTER III: THE DETERMINATION OF LEAD IN BLOOD VIA GFAAS 23
CHAPTER IV: EXPERIMENTAL PROCEDURES 38
LABWARE 38
REAGENTS AND STANDARDS 38
MATRIX MODIFIERS 39
INSTRUMENTATION 40
SAMPLE PREPARATION 42
CHAPTER V: RESULTS AND DISCUSSION 43
CHAPTER VI: SUMMARY 87
REFERENCES 89
VITA 92
iv
ACKNOWLEDGEMENTS
The writer wishes to express her deepest appreciation to Dr. Gary Rice, under 
whose guidance this investigation was conducted, for his patient criticism 
throughout the project and for the time he devoted to the careful reading of this 
thesis. The writer is especially grateful for the many hours he dedicated to 
tedious repairs. The author would also like to thank Dr. Christopher Abelt and 
Dr. William Starnes for their careful reading and criticism of this thesis.
Page
24
27
28
29
30
32
33
35
41
53
63
75
79
LIST OF TABLES
Temperature program for study done by Eaton and Holcombe
Temperature program for study done by Fernandez
Temperature program for study done by Fernandez and Hilligoss
Temperature program for study done by Pruszkowska, Camrick 
and Slavin
Temperature program for study done by Slavin and Parsons
Temperature program for study done by Hodges and Skelding
Temperature program for study done by Subramanian 
and Meranger
Temperature program for study done by Granadillo, Navarro 
and Romero
Example of a specific temperature program 
Revised procedural conditions
Modified temperature program for use with Pd method 
Optimized procedural conditions for plasma 
Optimized procedural conditions for whole blood
vi
Page
8
10
12
13
15
44
45
46
47
48
49
50
51
52
53
LIST OF FIGURES
The process o f atomic absorption
Schematic diagram o f an atomic absorption 
spectrophotometer
Diagram o f a hollow cathode lamp
Cross-section of a graphite furnace
L’vov platform inserted in a graphite tube
Double lead peaks observed using the Slavin method
Overcompensation of background signal observed using 
the Slavin method
Absorbance profiles for 5 ppb spiked serum at 30 mL/min and at 
0 mL/min purge gas flow during Atomization
Absorbance profile for 5 ppb spiked serum sample diluted 1:10, 
0.2% NH4H2PO4 and 0.5% Triton X-100 modifier solution
Absorbance profile for 5 ppb spiked serum diluted 1:1,
0.2% NH4H2PO4 and 0.5% Triton X-100 modifier solution
Comparison o f peak profiles for spiked serum diluted 1:10 using 
650°C char temperature and modifiers with and without HNO3
Absorbance profile for spiked serum sample diluted 1:1 using 
650°C char temperature and HNC>3 -containing modifier
Peak profile for spiked serum diluted 1:10 using 900°C char 
temperature and HNC>3 -less modifier
Comparison o f profiles for spiked serum diluted 1:1 with 
an atomization ramp of 1 and 3 sec
Aqueous standard with an atomization ramp o f 3 seconds
vii
16. Absorbance profile for 5 ppb serum diluted 1:10, Modified with 
0.5 mg/L Pd and 2% citric acid in 0.01 mol/L HNO3
17. Profile for serum diluted 1:10, using 1 sec 
atomization ramp
18. Comparison o f peak profiles using 0 and 2 sec atomization 
ramp times
19. Comparison of profiles for 1 :4 using both modifiers,
0.5 mg/L Pd and 5 mg/L Pd
20. Peak profile from 2 sec atomization ramp times
21. Peak profile from 4 sec atomization ramp times
22. Comparison o f signals produced using the modifiers 
containing 5 mg/L Pd and 50 mg/L Pd
23. Comparison of profiles for samples diluted 1:4, 
modifiers with 100 mg/L Pd and 300 mg/L Pd
24. Comparison o f profiles for samples diluted 1:4 and 1:1 
using the modifier with 100 mg/L Pd
25. Comparison of peak profiles using modifiers with 
100 mg/L Pd and 200 mg/L Pd
26. Comparison o f peak profiles using modifiers with 
50 mg/L Pd and 200 mg/L Pd
27. Comparison of peak profiles for plasma diluted 1:4 and 1:3, 
modifier containing 200 mg/L Pd
28. Comparison o f peak profiles for plasma diluted 1:4 using 
char temperatures of 700°C and 1000°C
29. Comparison of peak profiles for plasma diluted 1:2 using 
char temperatures of 1000°C and 1100°C
30. Profiles for various atomization temperatures with a 
char o f 1100°C using plasma diluted 1:2
Page
55
56
56
57
58
59
60
61
62
63
65
66
67
68 
69
viii
Page
69
70
71
72
73
75
76
78
78
81
Profile for a 30 ppb aqueous sample with the char at 
1000°C and the atomization at 2000°C
Profile for a 30 ppb aqueous sample with the char at 
1000°C and the atomization at 1700°C
Optimization of atomization temperatures for 
both aqueous and plasma samples
Comparison of profiles for various char temperatures 
with an atomization o f 1500°C using plasma diluted 1:2
Optimization of charring temperatures
Comparison o f peak profiles for both matrices spiked 
to 30 ppb
Calibration curves
Peak profile for 30 ppb plasma sample diluted 1:2 
Peak profile for 30 ppb whole blood sample diluted 1:2 
Calibration curves for whole blood
ix
ABSTRACT
The purpose of this study was to develop an effective and more sensitive 
method for the determination o f lead in blood by graphite furnace atomic 
absorption spectroscopy. Lead poisoning, and especially childhood lead 
poisoning, is a major public health problem in many industrialized countries. The 
presence of lead in the blood is regarded as a reliable index to the extent o f recent 
metal uptake. Therefore, the determination of lead in blood is useful in the 
diagnosis of poisoning and in monitoring the working environment.
Sample pretreatment consisted o f a 1:2 dilution with a dilute surfactant.
To eliminate the background absorption signal from the blood matrix, a matrix 
modifier solution of 200 mg/L Pd and 2% citric acid in 0.01 mol/L nitric acid was 
also deposited onto the furnace platform. In addition, an air atmosphere was used 
during the pyrolysis step to aid in the combustion o f matrix materials.
Values for lead in the samples were obtained by direct comparison to a 
linear working curve prepared from aqueous standards. An entire cycle could be 
completed approximately every two minutes.
The determinations were performed in triplicate, and the relative standard 
deviation was typically about 4% at low concentrations, indicative of very good 
precision. In addition, recoveries have ranged from 3 ppb to 50 ppb at low 
concentrations o f blood lead. The limit o f detection was estimated to be 0.5-1 
ppb.
The method proved to be rapid and simple, reliable and was reproducible. 
In addition, there are minimal chances for contamination as the procedure does 
not require the use o f many labwares and reagents. The only sample preparation 
is the dilution, and thus the procedure lends itself to automation. The rapidity o f 
the method and the requirement o f only tens o f microliter volumes of blood 
sample make the method potentially attractive for large-scale screening programs.
DETERMINATION OF TRACE LEVELS OF LEAD IN WHOLE BLOOD BY
GRAPHITE FURNACE 
ATOMIC ABSORPTION SPECTROSCOPY
Chapter I: Introduction
Lead in the Environment
Lead is a heavy metal of considerable utility and versatility, but is now a persistent 
and ubiquitous environmental problem. It has been used at least since Biblical times in a 
variety o f products, primarily in inorganic forms to the extent that its impact as an 
environmental pollutant was of little consequence until this century.(l,2,3) Lead pollution 
has increased greatly due to its use, in metallic form, in storage batteries and in the past as 
organic anti-knocking additives to petrol in the automotive industry.(1,3,4,5) It is estimated 
that over seven million tons o f lead were burned in the United States between 1926 and 
1985 through internal combustion engines, and it has been well documented that high 
concentrations o f lead are found in surface soils o f even remote ecosystems as a result of 
atmospheric deposition.(3) Only during the last two to three decades have efforts been made 
to recover lead from used batteries and to use alternative petrol additives.(l,2,4,6)
The health risks associated with exposure to lead are well recognized. There is now 
sufficient evidence to indicate that exposure to even low lead levels (<100ug/L blood) can 
produce adverse health effects, especially in more vulnerable segments of the population; 
including the unborn fetus, infants, children and the elderly.(7) Important sources of 
exposure to environmental lead include paint, dust and soil in and around dwellings.(l,4,5,6)
2
3In addition, lead in drinking water arising from lead piping, fixtures, and lead-based solder 
in household plumbing can also pose a significant risk.(l,4,5,6)
Chronic lead exposure is characterized by neurological defects, kidney dysfunction 
and anemia.(2,3,6,8) Neurological damage includes behavioral problems, intellectual 
impairment and hyperactivity.(l,4,8,9) Various researchers have suggested that the most 
controversial issue associated with the toxic effects o f lead exposure is in regard to subtle 
behavioral effects due to moderately elevated lead levels.(l) Human behavior is influenced 
by so many factors that the design o f studies taking these factors into account has been 
extremely difficulty 1 )
Anatomic data suggest that the kidneys are the most sensitive to lead.(l,2,3,6) 
Generalized aminoaciduria is a characteristic o f early lead nephropathy in both children and 
aduhs.(l,2,3,6) In children with acute exposure to lead (blood lead levels o f at least 150 
pg/dL), a complete renal Fanconi syndrome o f aminoaciduria, glycosureia and 
hyperphosphaturia may develop.(3) The anemia o f chronic lead poisoning is known to be 
due primarily to an inhibition of the enzyme which controls the incorporation of iron into 
the heme molecule.(2,3,4,6)
Overall, the current understanding of lead toxicity is considered inadequate, 
particularly with respect to neurobehavioral effects in man, and in defining the magnitude 
for maximum safe exposure levels.(l) However, in the United States the Centers for 
Disease Control has set the concentration o f blood lead (BPb) considered harmful. The 
chosen value was recently lowered from 25 to 10 pg/dL (100ppb).(10)
4The assessment of lead exposures from paint, dust, soil, food and drinking water 
requires the reliable determination o f lead in clinical samples. As a result, projects 
committed to the standardization of sampling, sample preparation, and analysis of lead in 
whole blood are a critical part of lead poisoning prevention.(7,ll) The most common 
analytical technique for the determination o f trace levels of lead in blood is through graphite 
furnace atomic absorption, as it requires only tens o f microliters o f sample and can provide 
detection limits up to 1 0 0  times lower than other conventional spectroscopic 
techniques.( 12,13)
Comparison of Spectroscopic Analytical Methods
A variety o f analytical methods have been used for the determination of lead in 
biological samples. Spectroscopic techniques include: inductively coupled plasma mass 
spectroscopy, inductively coupled plasma atomic emission spectroscopy, and flame and 
graphite furnace atomic absorption spectroscopy. Each of these methods will be 
described briefly.
Inductively Coupled Plasma Mass Spectroscopy (ICP-MS). ICP-MS is an efficient 
technique with low detection limits (ng/L range) and rapid sample throughput; however, 
instrumentation is expensive (>$100,000). An argon plasma is used as the ion source for 
a quadrupole mass spectrometer.(14) Spectral interferences do not occur in the normal 
sense o f ICP, but interferences from mass overlaps due to other elemental isotopes and
5polyatomic species produced in the plasma can occur.(14) These interferences may 
provide erroneous results, but can be reduced with high resolution instrumentation^ 14)
ICP-MS has proven to be a powerful technique for the determination of trace 
metals in various matrices.(13,14,15) Trace metal determination in biological matrices, 
however, can be very time consuming and tedious. Salts must be removed from high salt 
matrices before analysis due to interferences from mass overlaps.(14) Interferences may 
be corrected for by procedures such as principle component analysis or isotope 
dilution.(14) Salts are usually removed by chemical separation procedures, such as a 
solvent extraction procedure, which may introduce error and thus offset analytical 
advantages.( 13,14,15)
Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES). ICP-AES 
is the most widely accepted and utilized multielement atomic spectroscopy technique, as 
it can detect selected elements simultaneously or sequentially.(13,14,15) By monitoring 
selected analytical emission wavelengths for each element, either all at once or in a 
programmed sequence, many elements in a given sample can be determined in one 
automated analysis.(13,14,15) In addition, ICP-AES has an analytical working range of 
up to six orders o f magnitude.(13,14,15) This broad linear dynamic range enables the 
determination o f samples with widely varying concentrations. The detection limit (about 
20 fig/L) is the primary problem for the determination of lead in blood.(15) It is 
inadequate for routine determinations.
6The determination o f trace metals in biological samples by ICP-AES typically 
requires a separation o f the analyte from the matrix because high concentrations o f salts 
in these samples tend to clog the sample orifice o f the ICP torch.(14,15) This separation 
is time-consuming and can create difficulties in creating analytical blanks and in 
controlling contamination problems.
Flame Atomic Absorption Spectroscopy (FAAS). FAAS is a simple, rapid and 
precise method for trace metal analysis; however, large sample volumes are required and 
the limit o f detection for lead (40-50 pg/L) is insufficient for trace analysis.(13) The 
typical analytical working range is two to three orders o f magnitude^ 14) For the analysis 
of higher concentrations o f lead, FAAS may be the instrument o f choice. The 
determination o f lead at pg/L concentrations and below requires the use of 
preconcentration techniques, which are very tedious and time-consuming.(13,14) 
Preconcentration can be accomplished by several methods such as liquid-liquid extraction 
with an organic phase, ion exchange preconcentration, co-precipitation, and 
electrochemical methods. However, any preconcentration technique is slow and prone to 
contamination.
G raphite Furnace Atomic Absorption Spectroscopy (GFAAS). By far the most 
advanced and highly sensitive atomization method for atomic absorption is the graphite 
furnace. The limit o f detection for lead analysis by GFAAS is at least ten times better 
than FAAS; however, GFAAS has a limited analytical working range of a little over two
7orders of magnitude.(13,14) A single routine GFAAS determination for a single element 
normally requires two to three minutes due to the multiple step temperature program 
required. Only small sample volumes are required, which is particularly useful in the 
analysis o f biological samples. Matrix interferences can be controlled, in most cases, 
without the incorporation of extraction and preconcentration techniques. Thus, GFAAS 
appears to be the most useful o f the existing analytical methods for the determination o f 
trace levels o f lead in small biological sample volumes; however, many GFAAS systems 
with low limits o f detection and good precision and reproducibility require the use o f the 
costly Zeeman background correction systems and electrodeless discharge lamps. 
Further improvement in the methodologies could allow for improved simplicity and 
sensitivity for the technique. This would make GFAAS methods more attractive for 
routine lead screening programs using automated systems with sufficiently low limits o f 
detection and no sample pretreatment steps, other than simple dilution, with more 
accessible GFAAS instrumentation.
Chapter II: 
Graphite Furnace Atomic Absorption Spectroscopy
Introduction
GFAAS is a routine analytical method for the quantification o f many elements in a 
variety o f sample matrices. In order to understand this analytical technique, a brief 
description o f the theory behind atomic absorption and of the components o f the graphite 
furnace are necessary.
In atomic absorption, a liquid sample is typically reduced to atoms at elevated 
temperatures as a narrow band of electromagnetic radiation, typically in the ultraviolet 
through the visible region o f the spectrum, is passed through the sample.(12,13,16,17) The 
ground state o f the atom absorbs light energy of a specific wavelength and, through 
electronic transitions, the atom enters the excited state as illustrated in Figure 1.
+
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Figure 1: The process of atomic absorption. Ref. 16
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9The amount of light absorbed is directly proportional to the number of atoms in the 
beam. A quantitative determination o f the amount of analyte can be made by measuring the 
amount of light absorbed relative to known concentrations o f the analyte 
elemental2,13,16,17) Through the use of light sources specific to the given element and 
carefully chosen wavelengths, the selective determination of individual elements is achieved 
such that spectral interferences from other species are minimized.
The intensity of the incident radiation from the radiation source (Io) decreases after it 
passes through the gaseous atoms.(12,13,16,17) The remaining intensity (I) is given by the 
transmittance (T), where
T = I/Io.
The transmittance can then be related to the absorbance (A) by Beer's Law, which states
A = - log T = abc
where ‘a’ is the absorptivity coefficient for the absorbing species, 4b’ is the thickness of the 
sample cell (usually measured in centimeters), and ‘c’ is the concentration of the absorbing 
species. Thus, the extent o f absorption depends primarily on the concentration of the 
absorbing species since in practice the length of the sample cell is held constant. Absorption 
as a function of concentration should be linear over a range of analyte concentrations 
measured in the same sample matrix.
At sufficiently high concentrations most elements tend to deviate from Beer's Law in 
that the relationship between concentration and absorbance is no longer linear. There are 
many reasons for this, including nonhomogeneous temperatures in the absorbing cell, stray 
light, line broadening and self-absorption. ( 12,13,16,17) In order to correct for this,
10
microprocessors are incorporated into modem atomic absorption instruments which plot 
absorbance vs. concentration curves over a wide range of concentrations. The instrument 
then utilizes an automatic curve correction to determine elemental content when sample 
concentrations are beyond the linear range.
Instrumentation
Conventional models incorporate at least the following five instrumental 
components: a lamp as a source of electromagnetic radiation, a graphite tube as a sample 
cell in which atoms are produced, a monochromator for wavelength isolation, a detector 
which measures the light intensity and amplifies the signal, and a microprocessor system 
that will electronically interpret the signal.(12,13,16,17) A system to correct for background 
spectral interferences is usually incorporated as well. A schematic diagram of a typical 
GFAA instrument is shown in Figure 2.
Sc-ecL'ic Li^ht M fixaursnient
Scu rce
M co cchr cn: a: o r
Figure 2: Schematic diagram of atomic absorption spectrophotometer. Ref.16
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The light source that is typically used is a hollow cathode lamp (HCL), which 
produces a bright, stable and long-lived radiation source.(12,13,16,17) The energy required 
for atomization is provided by applying a high voltage electrical current through the graphite 
tube where the sample has been placed. A programmable power supply provides precise 
control o f temperature programs in the atomization process. The atomic vapor generated 
from the furnace can absorb light. The light is electronically modulated to differentiate 
between the light from the source and emission from the sample cell. The monochromator 
is used to isolate a specific wavelength for detection by a photomultiplier tube. An electrical 
current is then produced and processed depending on the intensity o f the light reaching the 
detector. A time-dependent signal is produced and either peak height or peak area can be 
measured and compared to a calibration curve in order to determine the analyte 
concentration.
Since atoms absorb light at very specific wavelengths, it is necessary to use a lamp 
that will provide the narrow-line spectra of the element o f interest. The hollow cathode 
lamp is a bright, stable source for most elements.(12,13,16,17) Figure 3 illustrates how a 
hollow cathode lamp is constructed. The lamp consists o f a tungsten anode and a cylindrical 
cathode sealed in a glass tube filled with neon or argon. The cathode is constructed entirely 
or in part of the metal whose spectrum is to be produced. Ionization o f the inert gas occurs 
when a potential on the order o f 300 V is applied across the electrodes, and a current ranging 
from 5 to 20 mA is generated as ions and electrons migrate to these electrodes. If  the 
potential is sufficiently large, a process called "sputtering" occurs in which the gaseous 
cations acquire enough kinetic energy to dislodge some of the metal atoms from the cathode
12
surface, thus forming an atomic cloud. These sputtered metal atoms are produced in excited 
states and they emit characteristic radiation in returning to the ground state. Eventually, the 
metal atoms are redeposited as they diffuse back to the cathode or to the glass walls.
NEON OR ARGON
ANODE
OPEN
SHIELD
CATHODE
O
Figure 3: Diagram of a hollow cathode lamp. Ref.16
The sample cell consists o f an electrically heated graphite tube into which the 
sample is deposited.(12,13,16,17) The graphite furnace, shown in Figure 4, is heated by 
applying a high current across the water cooled graphite contacts to resistively heat the
13
graphite tube for sample volatilization. The dimensions o f the graphite tube have been 
optimized, as the absorbance signal is dependent, among other variables, upon the residence 
time of the atoms in the sample tube.(10,16) Larger tubes tend to heat slowly and 
problematic temperature gradients along the tube length develop. Shorter tubes heat rapidly 
to the extent that the sample residence time would be too short.
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Figure 4: Cross-section of a graphite furnace. Ref. 12
Normal graphite has a relatively coarse, layered surface which allows certain 
materials and elements to penetrate into the lattice where they can interact with the graphite 
at elevated temperatures.(12,16,17) This can pose problems because the analyte may be 
retained by the graphite and released only at higher temperatures. Thus, graphite tubes are 
commonly coated with pyrolytic graphite to make the tubes more impervious to metals in
14
the vapor phase. Pyrolytically coated graphite tubes have a more uniform and dense surface 
that does not allow for sample or solvent penetration, and they are thus more chemically 
inert.
When wall atomization is used, the sample is deposited onto the wall in the center o f 
the tube.(12,16,17) This is the area o f the tube that is heated most rapidly and which reaches 
the atomization temperature first. Thus, the analyte is volatilized off o f the wall into an 
environment which is cooler than the surface from which it was volatilized. This leads to 
conditions that are very difficult to control and which can cause various matrix 
interferences.
In order to achieve atomization and volatilization at a more constant temperature 
throughout the tube, the sample is often atomized from a small platform of solid pyrolytic 
graphite inserted into the tube.(12,16,17) An illustration o f a L’vov platform inserted in a 
graphite tube is shown in Figure 5. The graphite tube is heated primarily by an electric 
current passing through it; however, the platform is heated primarily by radiation from the 
tube walls. Therefore, there is a time lag between the heating of the tube and the platform, 
which serves to delay the atomization o f the sample until the graphite tube and the inert gas 
reach thermal equilibrium. The L'vov platform has a proven reputation for providing greater 
control and reproducibility of the atomization conditions, and for reductions in sample 
matrix interferences.
15
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Figure 5: L’vov platform inserted in a graphite tube. Ref. 12
The graphite tube is completely enclosed in order to minimize environmental 
influences, except for the port through which the sample is deposited.(12,13,16,17) 
Removable quartz windows are located at both ends of the furnace to allow for passage o f 
the HCL beam. Two independently controlled gas flows are used. An external flow o f an 
inert gas protects the tube from ambient air exposure, which would cause degradation at 
high temperatures due to oxygen. Because an inert atmosphere during atomization is a 
prerequisite for any graphite furnace analysis, an internal gas flow is also used both before 
and after atomization. This gas protects the hot graphite from burning away through contact
16
with the ambient air and serves to purge the tube of any matrix materials volatilized during 
the pre-atomization dry and char steps. After atomization, the inert flow also serves to flush 
the tube o f any remaining materials from the sample. Argon is typically used for both the 
external protective and the internal purge gas, as it does not react with the graphite or with 
analyte atoms.
Alternate gases can be used during the thermal char o f samples with complex 
matrices, such as in the atomization o f biological samples.(12,16,17) The use of air as a 
purge gas during the pyrolysis step can provide a much more effective char and thus a more 
complete removal o f organic and biological materials, which may otherwise cause a carbon 
buildup on the inside o f the tube and interfere with the analysis.
Graphite tubes typically have lifetimes of 50 to 300 determinations, depending on 
atomization rate, temperature, the rate o f gas flow, and the composition o f the sample 
matrix.(12,16,17) As the tube ages, analytical precision will decrease. The use o f a L'vov 
platform typically results in a longer tube lifetime as the sample does not come into direct 
contact with the tube wall. In order to achieve the maximum useful tube lifetime the 
atomization temperature and time should be kept as low as possible. As the tube ages, the 
analytical peak may change in shape and the tube should typically be replaced when the 
absorbance value drops to about 20% below the original value.
Graphite furnace atomic absorption spectroscopy is not rapid due to the long interval 
between individual firings (2-3 minutes). Automatic samplers are almost a necessity for 
precise volume measurements and the reproducible deposition of samples into the graphite 
tubes. The manual deposition of a small volume of liquid into a small, dark sample opening
17
is very difficult and requires substantial analytical expertise. Furthermore, not only 
accurately dispensed volumes, but also the position o f the sample droplet in the graphite 
tube has an influence on the precision of the resuhs.(12,16,17)
Interferences
Interferences in graphite furnace atomic absorption are evidenced by either an 
enhancement or depression o f the absorbance signal when compared to an appropriate 
standard at the same concentration^ 12,16,17) Various categories o f interferences exist in 
atomic absorption; these are chemical interferences, ionization interferences, emission 
interferences, spectral interferences and background absorption.
Chemical interferences result when the sample contains thermally stable compounds 
of the element o f interest which do not decompose at the prescribed furnace 
temperatures.(12,16,l 7) As a result, the number of analyte atoms in the vapor phase capable 
of absorbing light is reduced. These interferences can usually be overcome with the use o f a 
higher atomization temperature, or through the use of chemical matrix modification. 
Increased atomization temperatures provide additional energy to break down the compounds 
that are stable at the lower temperature; however, more volatile elemental species may be 
lost in the process. Releasing agents or complexing cations can be added to preferentially 
react with the interferent to release the analyte at lower temperatures and indirectly remove 
the chemical interference.
Ionization interferences result when the furnace temperature has enough energy to 
cause the removal o f an electron from the atom, thus creating an ion.(12,16,17) This also
18
reduces the number of atoms in the ground state; and thus the extent o f atomic absorption is 
reduced. In order to minimize this type of interference, an excess of an easily ionized 
element can be added to both the standards and samples. Alternatively, a lower atomization 
temperature may be used; however, this may create other potential interferences.
The major emission interferences in graphite furnace atomic absorption 
spectroscopy are due to black body radiation from the furnace tube or from highly emissive 
species in the sample.(12,16,17) At low analyte concentrations, the atomic absorption 
analysis may exhibit poor precision if the emission signal falls within the spectral bandpass 
being used. This radiation is evidenced by increased noise or, occasionally, by baseline 
shifts. The emission signal is generally due to emission from the carbon tube itself; 
however, materials in the furnace or sample may also emit radiation. The slit width o f the 
monochromator may be decreased in order to somewhat compensate for this interference, 
resulting in some loss of sensitivity.
Spectral interferences result when an absorbing wavelength of a species present in 
the sample falls within the bandwidth of the absorption line of the element of 
interest.(12,16,17) In this case, analytical results will be erroneously high as the interfering 
element will augment the atomic absorption signal. A smaller slit width may be used or an 
alternate wavelength chosen to correct for spectral interferences.
Background absorption is a common interference in atomic absorption for which 
there are two primary sources: light scattering by particles in the vapor phase and molecular 
absorption o f light by molecules in the vapor phase.(12,16,17) Some samples, especially 
biological samples, may absorb or scatter light from the source due to the existence of
19
gaseous molecular species or salts in the vapor phase at the atomization temperature. In 
addition, the radiation from a continuum source used to measure background absorption 
may be absorbed by species from the matrix if they have an absorption line within the 
spectral bandpass being used for the analysis. Fortunately, low levels o f background 
absorption can be distinguished from the absorption of the element o f interest. The analyte 
element will only absorb the narrow line emitted by the source lamp; whereas background 
absorption is less specific and extends over a broad band of wavelengths.
The most common way to compensate for background absorption is through 
background correction, which subtracts non-analyte absorption signals from the total 
absorbance signal generated. The deuterium arc lamp continuum source background 
corrector, which is the most commonly used system for background correction, is designed 
to automatically correct for broad-band nonatomic absorption in the UV region from 195 
nm to 320 nm.( 12,13,16,17) The lamp, which is adjusted to equal intensity with the primary 
source, emits light over a broad spectrum o f wavelengths instead o f specific lines. The 
hollow cathode lamp and light from this continuum source are passed alternately through the 
furnace. The element being determined absorbs only the discrete lines from the hollow 
cathode lamp while background interferences can absorb light over the bandwidth o f the slit. 
The overall bandwidth (typically 0.2-0.7 nm) is quite large compared to the linewidth o f the 
atomic transition (0.001-0.0001 nm). Thus, there is negligible error in the background 
correction. Finally, the difference in the two beam intensities is measured electronically and 
used to eliminate the effect of the background absorption.
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Background correction with a continuum radiation source is limited in that it only 
accurately corrects for background absorption that is constant in intensity over the observed 
spectral bandwidth.( 12,16,17) When the background absorption changes with wavelength 
the continuum source background corrector will subtract the average background signal, 
which may not be identical to the actual background absorption on the resonance line and 
results in overcompensation. Any baseline offset in the vicinity o f the absorption signal or 
any over-compensation of the background is a clear indication of improper background 
correction. In order to prevent this, other background correction systems may be used, such 
as Zeeman or Smith-Hjeifte systems; however, these systems are far more costly.
Background absorption can also be reduced through several alternative means. 
Matrix modification through the addition o f other species to the sample will frequently 
reduce the effects o f background absorption. Alternatively, one can reduce the sample size 
by injecting less or by diluting the sample. Increasing the temperatures of the pre­
atomization steps may also reduce background absorption, particularly if the background 
signal is being produced by a volatile organic matrix constituent. One may also increase the 
flow rate o f the purge gas in order to decrease the residence time of the background- 
producing constituents in the furnace. Unfortunately, these alternatives also often result in 
poorer limits o f detection.
Optimization of Analytical Methods
In graphite furnace atomic absorption, the desolvation o f the sample, dissociation 
from the matrix, and the generation of analyte ground state atoms occur sequentially during
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the dry, char, and atomization steps respectively. Thus, it is necessary to select the 
individual temperatures such that each step is effectively carried out for its intended 
purpose.( 12,16,17)
In creating the temperature program, temperature ramping allows a controlled, 
gradual increase in the furnace temperature instead of a strictly stepwise procedure.
Stepwise procedures may be inadequate because the thermal treatment at any particular step
/
may be incomplete; thus causing the more volatile constituents of the matrix to dissociate, 
melt or rapidly boil when the temperature program abruptly advances to the next 
step.(12,16,17) This sample spattering may lead to poor precision and loss o f sample. By 
using temperature ramping, each of the constituents in a complex biological sample may be 
more effectively decomposed.
The purpose of all pre-atomization steps is to decompose and remove all matrix 
materials as thoroughly as possible so that the atomization of the analyte element can be 
carried out with minimal interferences.(12,16,17) The temperatures for these steps must be 
carefully chosen as they need to be long enough and the temperature high enough to 
completely volatilize any particulate-producing or interfering compounds. The purpose of 
the dry step is to evaporate low boiling liquids from the sample while the char step is used to 
remove as much of the matrix as possible before atomization. The physical properties o f all 
materials and compounds present in the sample matrix largely determine the success o f this 
separation. Thus, the thermal stability of the matrix in which the analyte element o f interest 
resides is of major significance. The more volatile the matrix materials and the less volatile 
the analyte element, the easier the separation. Thus, the addition of matrix modifiers can
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chemically convert the analyte to a less volatile form, or the matrix into a more volatile 
form.
Matrix modification has been proposed as a technique to transform elements into a 
more well defined compound with known properties in graphite furnace applications. This 
provides for the use of optimal temperature conditions for the thermal pretreatment o f the 
matrix.(12,16,17) Higher pretreatment temperatures ensure the best separation of the 
analyte from accompanying materials, and thus reduces the chance of encountering 
background interferences. Matrix modification may also help to avoid the appearance of 
multiple analyte peaks in the absorption profile due to the absorption o f different 
compounds of the analyte element present in the original sample that are volatilized at 
different temperatures.
The temperature selected for atomization must be high enough to completely 
volatilize the analyte element within a few seconds without loss o f analyte.(12,16,17) The 
atomization time is chosen to be as short as possible while still allowing for the complete 
volatilization o f the analyte element. If this time is too short, some of the analyte may be 
retained in the furnace, thus causing erroneous results for the following samples.
The external protective gas stream around the tube is normally fixed.(12,16,17) The 
purge gas stream, however, must be precisely controlled such that it completely removes all 
volatilized material from the tube without allowing it to recondense in cooler areas of the 
furnace. During atomization, however, the purge gas is stopped so that the analyte atoms 
are kept in the beam o f radiation as long as possible in order to give the highest absorbance.
Chapter IK: 
The Determination of Lead in Blood via GFAAS
Among the various techniques used for the determination o f lead in blood, 
electrothermal atomic absorption spectroscopy (ETAAS) is very popular because o f the 
excellent sensitivity and selectivity for lead.(18) Numerous methodologies have been 
published for ETAAS with wide variations in atomization, sample pre-treatments and 
analytical methods. Most methods involve simple dilution of the blood, normally with a 
haemolysing agent such as Triton X-100, and then introduction into the furnace for drying, 
ashing, and subsequent atomization. The main problem encountered in the application of 
electrothermal atomization to volatile analytes in samples containing appreciable amounts of 
organic matter is obtaining satisfactory separation o f the ash and atomization signals. This 
separation is necessary, even if a background correction system is employed, in order to 
obtain reliable resuhs.(12,16,17) Thus, numerous groups have developed methods to 
remove the organic interferences either by chemical modification of the matrix or through 
the use o f an oxygen pre-ash to aid in the combustion of interfering species.
Eaton and Holcombe published a comparative study which evaluated various 
matrix modifiers and procedures.(18) In particular, the roles o f O2  ashing, Triton X-100, 
HNO3 and NH4H2PO4 were studied. The group suggested a method for the determination
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of lead in human whole blood using GFAAS. As previously described, the use of 
temperature ramping allows for a more controlled, gradual increase in the furnace 
temperature; whereas a strictly stepwise procedure as performed here can cause the more 
volatile constituents of the matrix to dissociate, melt or rapidly boil when the temperature 
program abruptly advances to the next step.(12,16,17) The temperature program used in 
this study is provided in Table 1.
Step Furnace
Temperature
(°C)
Ramp
Time
(s)
Hold
(s)
Internal 
Gas Flow 
(mL/min)
Dry 100 0 45 200
Char 900 0 45 200*
Atomization 2000 0 3-5 200
Cool-down 25 0 25 200
’•'Denotes the alternate gas, air.
Table 1: Temperature program for the study done by Eaton and Holcombe
The method did not utilize a continuum background correction system, thus the 
reduction of spectral interferences was a primary concern. The high salt concentration o f 
blood was reduced by using red cells rather than whole blood, as previous research has 
clearly shown that lead tends to adsorb on the surface of red cells. Sample preparation 
involved centrifugation of the blood in order to isolate the whole red cells from the blood 
plasma. This, however, can be tedious, timely and can introduce sampling errors and 
contamination.
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Background measurements were made with the 280.3nm line o f lead.(18) Ash 
buildup was noted after several firings which was difficult to remove even with a high 
temperature burnout in the inert sheath gas. Thus, an air ashing was used to remove the 
carbonaceous deposits. Air, which is approximately 20% O2 , was used at 2.0 L/min during 
the dry and first ash step of the temperature program. In the absence o f air a maximum ash 
temperature o f 500° C could be utilized without a significant loss o f lead; however, in the 
presence of air ash temperatures of up to 950 °C were used. This temperature was 
sufficient to ensure combustion o f the matrix without analyte loss. The group suggested 
that 0 2 was adsorbed as a surface oxide on the graphite and desorbed as CO. The CO 
was only released at an appreciable rate at elevated temperatures of greater than 1000° C. 
Thus, only a few monolayers o f the graphite were removed on every firing as long as an 
inert atmosphere existed within the furnace at temperatures greater than 1000° C.
The study also confirmed the utility of Triton X-100 in blood analysis.( 18) This 
surfactant reduced the sample/graphite interfacial tension and allowed improved contact 
between the sample and the furnace walls. Without the addition of the Triton X-100, the 
majority o f the sample was physically lost from the furnace due to frothing during the 
dry, and the subsequent ashing was ineffective due to poor contact with the graphite tube. 
Several concentrations o f Triton X-100 were used, ranging from 0.1 to 5.0% (v/v). At 
higher concentrations, interfacial tension was so reduced that the sample flowed out o f 
the ends of the graphite tube resulting in a loss o f signal.
Many studies have indicated that the addition of low concentrations o f HNO3 will 
stabilize aqueous solutions o f lead standards and prevent adsorption o f the metal onto the
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storage container walls. However, this study determined that significant variations in 
peak heights and areas caused by minor changes in acid concentrations outweighed the 
benefits o f its use. Many researchers have also added phosphate salts, such as 
NH4 H2 PO4 , as matrix modifiers to facilitate the determination o f lead in blood. However, 
the study also indicated that the addition o f phosphate salts to whole blood and whole red 
cells resulted in considerably higher background absorbances. The addition of 
NH4H2 PO4  to aqueous lead standards and blood samples also allowed for higher 
temperatures to acquire the absorbance peak; however, no explanation for this 
phenomenon was postulated.
Fernandez also developed a method for lead determinations in whole blood by 
GFAA in which no matrix modifiers were used, other than a simple fivefold dilution of 
the blood with 0.01% Triton X-100 surfactant.(19) When the samples were diluted with 
de-ionized water, an appreciable buildup o f residue from the blood matrix was observed 
in the tube, making the use of simple aqueous dilution impractical. Hemolysis o f the 
blood by dilution with the diluent eliminated this residue buildup problem. The use of 
various dilution ratios was investigated, and it was found that a fivefold sample dilution 
provided the best compromise between adequate sensitivity and low background 
absorption. To eliminate the nonspecific absorption signal from the blood matrix, a 
deuterium arc background correction system was used.
The procedure recommended by Fernandez was problematic for the same reasons as 
was the aforementioned procedure. The temperature program provided below in Table 2 
was suggested as optimum; however, it did not include the use o f temperature ramps. In
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addition, the char temperature was very low, and thus may not have removed all potential 
interferences.
Step Furnace Ramp Hold Internal
Temperature Time Gas Flow
(°C) (s) (»> (mL/min)
Diy 100 0 25 15
Char 525 0 50 15
Atomization 2300 0 9 15
Table 2: Temperature program for the study done by Fernandez
The average recovery was studied by adding known amounts o f lead nitrate to 
several blood samples. This recovery was typically around 98% over a concentration 
range of 150-1000 pg/L with precisions ranging from 2-4%. However, this concentration 
range is not a realistic range to study as the Centers for Disease Control recently lowered 
the concentration of blood lead considered harmful to young children from 250 to 100 
pg/L. Thus, a routine method for pediatric screening must be able to accurately and 
precisely detect blood lead levels lower than 100 pg/L. In addition, this method involved 
a centrifugation procedure to mix the diluted blood samples, which was tedious and can 
lead to contamination and transfer error.
Fernandez and Hilligoss developed a different method for the determination of 
lead in blood using the graphite fumace.(20) However, the paper was short and 
inconclusive, and no limit o f detection was mentioned. The method involved a fivefold
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dilution of blood in 0.5% Triton-X 100, matrix modification with 0.2% NH4 H2 PO4 , 
deuterium arc background correction and utilization o f the L’vov platform.
In contrast to the findings o f Eaton and Holcombe, the results o f this study 
indicated that the use o f NH4H2PO4 virtually eliminated any background interferences 
and residue buildup from the blood matrix, thus significantly extending the lifetime o f the 
graphite tube.(lO) However, this discrepancy may be due to the fact that this group 
utilized whole blood whereas Eaton and Holcombe used only red cells. Thus, these 
results indicated that phosphate salts might be of some utility in reducing salt 
interferences when using complex biological samples such as whole blood.
Step Furnace
Temperature
(°C)
Ramp
Time
(s)
Hold
(s)
Internal 
Gas Flow 
(mL/min)
Dry 130 10 5 0
Dry II 200 15 20 0
Char 600 15 45 0
Atomization 1700 0 6 40
Cleanout 2500 1 4 0
Table 3: Temperature program for the study done by Fernandez and Hilligoss
The prescribed temperature program shown in Table 3 was more typical than the 
one previously suggested by Fernandez, as it included the use o f temperature ramps and 
cleanout; however, the suggested char temperature was low. In addition, the study 
suggested the use o f an internal argon flow during atomization, but this purge gas was not 
used for any other step. Ordinarily, the purge gas is used to force some of the vaporized
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matrix materials and burned organic residue out o f the furnace prior to atomization and 
during the cleanout. The use o f the purge gas during atomization; however, may have 
forced some of the lead atoms out o f the furnace and attenuated the signal. The samples 
were also noted to rapidly clot and suspend particulate matter, which noticeably degraded 
both precision and accuracy.
Pruszkowska, Camrick and Slavin also suggested a procedure for the 
determination o f lead in blood using a combined modifier containing 0 .2 % NH4 H2 PO4  
and 0.05% Mg(NO)3 .(2 1 ) In addition, 1% HNO3 was added to the solution in order to 
prevent the precipitation o f magnesium phosphate.
This procedure involved a two step deposition o f the samples onto the L’vov 
platform. First, a 10 pL aliquot of the blood sample diluted 10-fold in de-ionized water 
containing 0.2% Triton X-100 was automatically dispensed onto the platform using an 
autosampler. A 5 pL aliquot o f the modifier solution was then added on top o f the 
previously deposited samples and standards. The temperature program was typical for 
the determination of lead in blood, as given in Table 4.
Step Furnace
Temperature
(°C)
Ramp
Time
(s)
Hold
(s)
Internal 
Gas Flow 
(mL/min)
Dry 130 1 60 300
Char 650 1 45 300
Atomization 1700 0 5 0
Cleanout 2600 1 6 300
Cool-down 20 1 20 300
Table 4: Temperature Program used for the study done by Pruszkowska, Carnrick 
and Slavin
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The use o f this method, along with a magnetic Zeeman background correction 
system and an electrodeless discharge lamp running at 10 Watts, enabled the group to 
reach a sensitive limit o f detection o f 10 pg/L. In addition, a 93-101% recovery was 
reported, and the results were in good agreement with those from the Yale-New Haven 
Hospital, which also analyzed the lead content o f the samples. The reported precision 
was better than 2.5% at levels o f 200 pg/L.
One problem that was noted involved the appearance of a small, early-running 
peak in the blood which was perhaps due to the absorbance o f lead volatilized as the 
chloride. In addition, this method has proven to be impractical for reproduction when 
used with the more accessible and less costly deuterium arc background correction 
system due to the appearance of high background signals and suppressed analyte signals.
Slavin and Parsons developed a different method for the determination o f lead in 
blood via graphite furnace atomic absorption which was more rapid than any o f the others 
previously described.(17) This method, with Zeeman background correction, again 
cannot be easily replicated using a deuterium arc background correction system. Whole 
blood was diluted 1:10 in a phosphate modifier containing 0.2% NH4H2PO4, 0.5% Triton 
X-100 and dilute nitric acid with sampling on a L’vov platform. Except for the small 
purge gas flow during atomization the temperature program was typical as shown in 
Table 5.
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Step Furnace
Temperature
(°C)
Ramp
Time
00
Hold
00
Internal 
Gas Flow 
(mL/min)
Dry 175 5 1 0 300
Dry II 260 5 1 0 300
Char 900 5 2 0 300
Atomization 1900 1 5 30
Cleanout 2500 1 2 300
Table 5: Tem perature program used in the study done by Slavin and Parsons
An entire cycle was completed every 115 seconds with standard deviations 
typically about 2.5 pg/L at concentrations o f 100 pg/L, indicative of very good precision. 
The method appeared to be rugged and reliable as well as precise and accurate, as it 
rapidly determined concentrations down to 10 pg/L.
Hodges and Skelding described a method for the determination o f lead in blood 
by atomic absorption spectroscopy with electrothermal atomization using a very unique 
matrix modification technique.(22) The method proposed a matrix modification solution 
comprised o f 1% orthophosphoric acid, 1% HNO3, and 0.1% Triton X-100. In addition, 
a pre-coating of the graphite tube with molybdenum was suggested in order to most 
effectively minimize matrix interferences and to promote stable routine operation.
The addition of the orthophosphoric acid was effective in raising the atomization 
temperature of lead, thereby allowing greater time resolution of the ash and atomization 
processes. The lowest temperature at which atomization was detectable was reportedly 
increased from 630 to 840° C in the presence of the orthophosphoric acid. It was 
proposed that the substitution o f more volatile anions by orthophosphate was beneficial in
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minimizing if not eliminating the interference of halide and sulfate salts. The role of 
molybdenum as a coating for carbon tubes was not clear; however, it was postulated that 
the coating played some part in modifying the matrix so that background absorption due 
to phosphate salts was reduced. Overall, the molybdenum-coated tubes appeared to allow 
more reproducible analyte absorption signals to be obtained from the various blood 
samples.
The temperature program did not include the use o f temperature ramps between 
steps or a step for the HGA cleanout. In addition, no internal purge gas was mentioned. 
The temperature program is shown in Table 6 below.
Step Furnace Ramp Hold Internal
Temperature Time Gas Flow
(°C) (s) (s) (mL/min)
Dry 100 0 60 0
Char 750 0 30 0
Atomization 2500 0 2-5 0
Table 6: Temperature Program used for the study done by Hodges and Skelding
Over the extended study the method appeared to be reliable and it exhibited consistently 
good performance in regards to both precision and accuracy. The limit o f detection was 
50 pg/L, a value too high for the procedure to be realistically adopted for lead screening 
projects. The precision could probably have been improved if the samples were not 
manually injected. Additionally, the method involved more than one transfer of the 
blood sample into various flasks, the manual coating o f the graphite tubes with
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molybdenum, and the use of a calibration curve created by the method of standard 
additions. These procedures are timely and impractical for routine screening procedures.
Subramanian and Meranger suggested a rapid graphite furnace atomic absorption 
spectrometric procedure for the determination of lead in heparinized human whole blood 
using a slightly different phosphate salt for matrix modification.(7) In this method, a 
known aliquot o f the blood sample was diluted fivefold with an aqueous solution 
composed of diammonium hydrogen phosphate and Triton X-100. A deuterium arc 
background correction system was utilized with a lead electrodeless discharge lamp to 
enhance the sensitivity o f the technique. Nitrogen was used as the purge gas.
The most consistent results were obtained for a fivefold dilution o f blood with 5 g 
of (NH4 )2 HP0 4  and 5 mL o f Triton X-100 per liter over the range of charring 
temperatures investigated, which was suggested as the matrix modification solution o f 
choice for use in the determination o f lead in blood. More specifically, it was postulated 
that the NH** cations helped to minimize the matrix interferences from NaCl through the 
formation of the more volatile NH4 CI species. The temperature program did not include 
the use o f temperature ramps and a step to cleanout the HGA was not included as shown 
in Table 7.
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Step Furnace Ramp Hold Internal
Temperature Time Gas Flow
(°C) (») (■) (mL/min)
Dry 100 0 50 313
Char 700 0 30 313
Atomization 2300 0 8 0
Table 7: Tem perature program used for the study done by Subram anian and 
M eranger
The detection limit for the proposed procedure was 10 pg/L, with precisions typically 
about 6%. The mean recovery o f lead from spiked samples was reported to be 98.7%. 
The method was simple with minimal chances for contamination as it did not require the 
use of many labwares and reagents. The only sample preparation involved was the 
fivefold dilution of the blood with the matrix modification solution, and thus the 
procedure lended itself to automation. Finally, the method was rapid enough to complete 
one determination every two minutes, and required only microliter volumes o f blood 
sample, thus making the method even more attractive for large-scale screening projects.
Granadillo, Navarro and Romero studied the behavior of lead in electrothermal 
absorption spectroscopy with graphite furnace atomization using palladium or phosphate- 
magnesium induced matrix modification in conjunction with the carbon-reducing effect 
achieved by the addition of citric acid.(23) The matrix modification solution contained 
0.5 mg/L o f palladium and 2% m/v citric acid in 0.01 mol/L nitric acid. For comparison 
purposes, a matrix modification mixture consisting of 0.6% m/v NH4H2PO4 and 0.3% 
m/v Mg(NC>3 ) 2  in 0.01 mol/L nitric acid was also used.
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Under an oxygen atmosphere, the lead absorption signal for both matrix 
modification techniques was shifted later in time than with an inert atmosphere. These 
results suggested a carbon dependent mechanism for the reduction o f the atomic 
precursor to form lead atoms with the production o f CO. In addition, a simple method for 
the determination o f lead by stabilized temperature platform furnace electrothermal 
atomic absorption spectroscopy in clinical samples was developed using palladium- 
induced matrix modification, citric acid, and an O2  pyrolysis. The temperature program 
is given in Table 8.
Step Furnace
Temperature
(°C)
Ramp
Time
(s)
Hold
(s)
Internal 
Gas Flow 
(mL/min)
Dry 120 5 5 300
Dry II 250 20 10 300
Char 600 30 15 300*
Atomization 2000 0 5 0
Cleanout 2700 1 1 300
♦Denotes the alternate gas, air.
Table 8: Temperature program used for the study done by Granadillo, Navarro 
and Romero
The limit o f detection was 13 pg/L with recoveries ranging from 94 to 104% and 
a relative standard deviation o f 2.2%. In addition, the method was reported to be free 
from interferences, and it appeared to be reliable and reproducible.
The matrix modification solutions were not combined directly with the sample 
specimens in order to prevent the formation o f any precipitate, as this problem had been
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reported with other procedures. A significant amount of a carbon-containing residue was 
deposited in the graphite tube when no alternate gas was used. These deposits then 
increased after consecutive firings until they reached a point at which the optical beam 
was obstructed. This problem was too significant to be corrected by the deuterium arc 
background correction system, thus, the air pyrolysis was utilized. This successfully 
prevented the build-up o f the obstructing residue and uniformly dispersed the fine 
carbonaceous material across the platform. In addition, no significant deterioration of the 
graphite tube was reported because the oxygen reacted preferentially with the organic 
material.
The proposed method for the determination o f lead in whole blood was simple 
and lended itself to automation, as most systems can be easily programmed to inject the 
sample and modifier in sequence, and to automatically switch to the alternate gas at 
pyrolysis. However the whole blood was diluted ten-fold and the limit of detection could 
be improved with lesser dilution.
Many o f the aforementioned methods have taken advantage of a variety of 
combinations o f matrix modifiers, unique temperature programs, extractions and other 
sample preparations to enhance the limit o f detection, precision and reproducibility for 
the routine determination o f lead in blood. The best results have tended to be associated 
with GFAA systems utilizing the Zeeman background correction system; however, these 
are high end systems not readily available in many laboratories. Furthermore, 
preliminary studies in our laboratory have indicated that the procedures prescribed for use 
with the Zeeman background correction system do not work with the more conventional
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deuterium arc background correction system. In some instances a clean peak was not 
attainable at all, and when signals were obtained the precision and reproducibility were 
consistently lacking. Furthermore, there may be other modifier combinations or 
temperature variations which could potentially provide a reliable method for routine 
determinations with GFAA systems utilizing the more conventional deuterium arc 
background correction system. Thus, the emphasis o f this project was to develop a 
rapid, simple, reliable and accurate method for the determination o f lead in blood, using a 
more conventional GFAA system, with an enhanced limit o f detection suitable for routine 
lead screenings.
Chapter IV: 
Experimental Procedures
Labware
All glassware and Nalgene polyethylene containers were detergent washed, rinsed 
with deionized water, and soaked in 10% (v/v) HC1 to prevent possible contamination 
from lead adsorption onto the container surfaces. A final rinse was then performed with 
semiconductor grade deionized water. All volumetric pipettes were soaked overnight in a 
high-density polyethylene container filled with 10% (v/v) HC1 and then rinsed with tap 
water followed by thorough rinsings with semiconductor grade deionized water. All 
glassware and containers were covered or capped after washings and drying to prevent 
any contamination from the laboratory environment.
Reagents and Standards
Fisher “Reagent” grade HC1 was used for the cleaning of the laboratory 
glassware. Fisher “Trace Metal” grade HNO3 was used for modifier preparation and for 
the acid blank calibration solutions. The certified metal impurity for lead in the 
concentrated HNO3 is 0.4 ppb.
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The semiconductor grade deionized water was produced by first passing 
laboratory deionized water through a particulate filter and then through a semiconductor 
grade deionizing cartridge. A polybutylene tap was connected directly to the deionizing 
system to avoid contamination from the metal spigots. This system produces deionized 
water rated at 18 megaohms in resistance. Acid blanks and deionized water were 
periodically checked for contaminations.
Human blood serum and plasma, and pig blood plasma were obtained from the 
Sigma Chemical Company as a lyophilized powder. The samples and standards were 
diluted in 0.1% (v/v) Triton X-100. Human blood was drawn from Dr. Gary Rice and 
stored in a sealed heparinized tube. The whole blood was diluted in 0.5% (v/v) Triton X- 
100. “Electrophoresis Grade” Triton X-100 was obtained from Fisher Scientific and was 
subsequently diluted in deionized water. Triton X-100 is a nonionic surfactant with the 
formula C8Hi7 (C6 H4 )(OCH2 CH2 )xOH and an average molecular weight of 628 g/mol.
Plasma, serum and blood solutions with known lead concentrations were prepared 
by the method o f standard additions. This was done by spiking the diluted organic matrix 
with a standard lead solution. The standard solution was prepared from a commercially 
available lead atomic absorption standard from Aldrich with a certified concentration of 
1000 pg/mL, and successive dilutions were made to create working standard solutions o f 
500 pg/L and 100 pg/L. The standards were transferred into Nalgene polyethylene bottles 
for storage in order to minimize surface adsorption. The blood matrix solution was spiked 
with the appropriate amount o f standard in order to produce the desired blood lead 
concentration. For example, if 10 ppb blood lead concentration was desired in a blood
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sample that was diluted 1 :1 , the solution would contain 2 0 0  pL of blood, 2 0 0  pL of 0 .1 %
Triton X-100, and 4 pL of the spike to produce a total lead concentration of 10 pg/L.
(4pLt*(500pg/U) = 10 pg/L
200 pL
Matrix Modifiers
Various matrix modifier solutions were prepared over the course of the study. A 
modifier solution containing 0 .2 % w/v NH4H2PO4, 0.5% v/v Triton X-100 and 0.2% v/v 
HNO3 was prepared from ammonium dihydrogen phosphate from the Aldrich Chemical 
Company that was reported to be 99.9999% pure. Fisher “TraceMetal Grade” HNO3 was 
used. Later in the study, solutions containing 0.2% w/v NH4H2PO4 and 0.05% Mg(NC>3)2 
with and without the addition o f 1% v/v HNO3 were also prepared. Magnesium nitrate 
hexahydrate, reported to be 99.995+% pure, from the Aldrich Chemical Company was used. 
Other variations in these concentrations were investigated over the course of the study in an 
effort to optimize modifier concentrations.
The palladium matrix modification solution was prepared from a palladium nitrate 
matrix modifier solution containing 0.2% Pd in 2% HNO3 by Specpure from Alfa AESAR. 
Ten mL of the original solution, which contained 2000 mg/L, was diluted into the final 
solution by adding 84.3 mL deionized water, 5.7 mL o f HNO3 and 2.0 g of citric acid. The 
citric acid monohydrate powder was obtained from the J.T. Baker Chemical Company, and
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was reported to contain <0.3 ppm Pb. The resulting solution then contained 200 pg/mL Pd, 
2% citric acid and 0.01 mol/L of nitric acid.
Instrumentation
All atomic absorption determinations were made with a Perkin-Elmer Model 1100B 
Atomic Absorption Spectrophotometer equipped with an HGA 700 Graphite Furnace. The 
AS-70 Autosampler was used for all sample introductions using polycarbonate sampling 
cups. A Fisher single element hollow cathode lead lamp was used for the determination of 
lead. The default software choices for the analytical wavelength (283.4 nm) and the lamp 
current (10 mA) were used. The bandwidth slit height set on the monochromator was 0.7 
nm low; however, a slit width o f 0.2 nm low was also investigated.
A significant aspect o f optimization involved variations in the temperature programs 
to provide the most enhanced and reproducible absorption signals. Signals were taken in 
triplicate with 2-6 second integration times and a zero second read delay. An internal argon 
gas flow o f 300 mL/min was maintained throughout the graphite tube for every step of the 
temperature program except pyrolysis and atomization. An air flow of 300 mL/min was 
used for pyrolysis, and no internal gas flow was used for atomization. An example o f 
specific instrument conditions used is provided in Table 9.
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Step Furnace
Temperature
(°C)
Ramp
Time
0 0
Hold
(s)
Internal 
Gas Flow 
(mL/min)
Dry 150 2 0 2 0 300
Char 1 0 0 0 15 30 300*
Atomization 1650 0 1 0 0
Cleanout 2700 1 7 300
* Denotes the alternate gas, air.
Table 9: Example of a specific temperature program
Four point calibration curves were generated from aqueous and plasma standards 
using optimized temperature programs. Auto-zero (absorbance set to zero) was measured 
using 1% HNO3 with a deuterium arc continuum background correction system.
Sample Preparation
The serum and plasma samples were obtained in a lyophilized powder form and 
reconstituted with 2.0 mL of deionized water. All serum and plasma samples were kept 
refrigerated until used and discarded when clotting was evident. The whole blood sample 
was kept at room temperature. Test portions of the sample and standard blood, plasma 
and serum solutions were prepared fresh prior to each series o f runs by diluting the 
samples to ratios (ranging from 1:1 to 1:10) in dilute Triton X-100. They were thoroughly 
mixed by pumping the pipettes used in transferring them to the sample cups for the AA 
autosampler.
Chapter V: 
Results and Discussion
This project began with an attempt to reproduce the method used by Parsons and 
Slavin (10); however, human blood serum was used instead of whole blood since the 
primary interferences in blood were suspected to be associated with salts in the blood 
plasma. A matrix modifier solution containing 0.2% w/v NH4 H2 PO4 , 0.5% v/v Triton X- 
100 and 0.2% v/v HNO3 was made in accordance with the method, and temperature 
programs for the furnace were used as recommended. The primary difference in 
instrumentation was the use o f a continuum source background correction system instead 
of the Zeeman background correction system used by Slavin.
The first problem encountered was the occurrence of double peaks and signal 
suppression on all o f the lead , an example o f which is shown in Figure 6 . The double 
peaks may have occurred because the matrix modifier solution was deposited onto the 
platform and then the diluted serum sample was automatically deposited on top to limit 
the time spent on sample loading. This may have resulted in inadequate mixing and in 
the formation of lead species with different volatilities at the 1900°C atomization 
temperature used.
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Figure 6 : Double lead peaks observed using the Slavin method
Parsons and Slavin diluted the blood samples directly with the matrix 
modification solution and mixed the samples well with Eppendorf pipettes. When this 
technique was used the double peaks disappeared; however, signal quenching due to the 
matrix o f the blood serum was encountered. The background may have been sufficiently 
high to cause the baseline and signal to be suppressed as shown in Figure 7. Although 
the signal is apparent, it is prematurely quenched by background overcompensation. This 
may have been due to the instrumentation, since Parsons and Slavin utilized the Zeeman 
background correction system which can compensate for background signals more 
effectively.
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Figure 7: Overcompensation of background signal observed using the Slavin 
method
In an attempt to remove the matrix interferences causing the high background, the 
ashing temperature was held for 25 seconds instead o f the 1 0  seconds recommended by 
Parsons and Slavin. A significant improvement in the signal was detected, probably 
because more o f the interfering species were removed prior to atomization. Lower rates 
of inert gas flow were tried during the atomization step using a blood serum sample 
spiked to 5 ppb with an aqueous lead standard. At a 30 mL/min flow, as recommended 
by Parsons and Slavin, the average absorbance peak area obtained over three 15 pL 
sample injections was 0.025 A-s. This average steadily increased to a maximum o f 0.085 
A-s as the inert gas flow was lowered stepwise to 0 mL/min. Although the purge gas 
flow was forcing out some o f the matrix interferences, it was also forcing out lead atoms 
during the atomization step and thus attenuating the signal. Examples o f typical 
absorption profiles are shown in Figure 8 .
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Figure 8 : Absorbance profiles for 5 ppb spiked serum at 30 mL/min and at 0 
mL/min purge gas flow during atomization
In order to improve reproducibility, a new modifier solution was made containing 
the original mix o f chemicals without the addition o f nitric acid, as recommended by 
Eaton and Holcombe.(18) This did in fact result in an improved reproducibility; 
however, signals from the blood serum samples still were attenuated relative to the 
aqueous lead standards.
In addition, a major attenuation in the signal was observed as the sample aliquots 
of a 25 ppb aqueous standard, made up in the dilute modifier solution containing 0 .2 % 
w/v NH4 H2 PO4  and 0.5% Triton X-100, were increased from 15 pL to 50 pL for deposit 
in the furnace. This certainly should not have occurred as there were no salts or other 
species present in the aqueous standards to interfere with the signal. Visual inspection of 
the deposit o f the sample on the platform revealed that the Triton X-100 surfactant was 
reducing the surface tension in the aqueous standards to the extent that the larger volumes 
were rolling right off o f the L’vov platform, which is capable o f holding up to a 50 pL
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maximum aliquot size. Aqueous aliquots over 25 pL repeatedly rolled off o f the 
platform, resulting in a loss o f signal and reproducibility. Unfortunately, the 25 p.L 
volume limit could not be surpassed using a different surfactant because Triton X-100 is 
universally recommended for blood samples to prevent clotting and precipitation.
Although Parsons and Slavin recommended a sample dilution of 1:10 with the 
modifier solution, the limit o f detection could be improved significantly if reproducible 
signals could be obtained from serum samples with a lesser dilution. Thus, one serum 
sample was diluted 1:10 with the 0.2% w/v NH4H2PO4 and 0.5% v/v Triton X-100 matrix 
modification solution and spiked to 5 ppb, and another was diluted 1:1 with the same 
modifier solution and also spiked to a 5 ppb lead concentration. The signals for the 
samples diluted 1 : 1 0  were well formed and produced a reproducible signal with little 
attenuation as shown in Figure 9. The samples diluted 1:1 were very poor with no 
reproducibility as shown in Figure 10. The background signal was markedly higher and 
beyond the limits o f instrumental compensation.
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Figure 9: Absorbance profile for 5 ppb spiked serum diluted 1:10, 0 .2 %NH4 H2 PO4  
and 0.5% Triton X-100 modifier solution
Figure 10: Absorbance profile for 5 ppb spiked serum diluted 1:1, 0.2% NH4 H 2 PO 4
and 0.5% Triton X-100 modifier solution
A new approach was undertaken to minimize the dilution ratio required. The 
modifier solution prescribed by Pruszkowska, Camrick and Slavin was prepared in a 
manner similar to the previously tested solution in that it contained 0.2% NH4 H 2 PO4  
with the addition o f 0.05% Mg(NC>3 ) 2  diluted in 1% HNO3 . Pruszkowska et. al. noted 
that the nitric acid was added in order to prevent the precipitation o f magnesium 
phosphate. A solution not containing the nitric acid was also prepared. No precipitation 
problems were detected.
Pruszkowska, Camrick and Slavin recommended a lower char temperature o f 
650°C, as that temperature was sufficiently high to eliminate the background 
interferences in their findings. Zeeman background correction was again used. It was 
anticipated that a higher char temperature would be necessary in this study, as the 
deuterium arc background correction system is not as efficient as the Zeeman. Thus, char 
temperatures o f 650°C and 900°C were tested with both the acidified modifier solution
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and the one without, using serum samples diluted 1:10 and 1:1 with 0.2% Triton X-100 
and spiked with lead to 5 ppb.
First, the signal produced with the modifier solution containing 0 .2 % NH4 H2 PO4 , 
0.05% Mg(NC>3 ) 2  and 1% HNO3 was compared with the solution with no acid. The 
650°C char temperature was used with the sample diluted 1:10. Both sets o f signals 
proved to be reproducible; however, the signal produced from the sample modified with 
the HNC>3 -containing modifier consistently appeared earlier and with a much lower peak 
height than that produced from the sample modified with no HNO3 , as shown in Figure 
11. When these conditions were tried with the serum sample diluted 1:1, the results for 
both char temperatures and both modifier solutions were very erratic and not at all 
reproducible, as shown in Figure 12. Once again the signal suppression caused by the 
large background and chemical interferences from the serum constituents was substantial.
T  T H i
Figure 11: Comparison of peak profiles for spiked serum diluted 1:10 using 650°C 
char temperature and modifiers with and without HNO3
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Figure 12: Absorbance profile for spiked serum diluted 1:1 using 650°C char 
temperature and HNC>3 -containing modifier
Next, both modification solutions were tried with both sample dilutions using the 
900°C char temperature. As was expected, the signals for the samples diluted 1:10 were 
higher with the higher char temperature, as more o f the matrix interferences were burned 
out o f the sample prior to atomization. The signals from both modifier combinations 
were identical. A signal produced from the acidless modifier is shown in Figure 13. The 
signal profiles were similar to those obtained at the 650°C char, and repeated runs proved 
the technique to be reproducible when using the modifier without the nitric acid. Thus, it 
was determined that the higher char temperature was more effective when using this type 
of procedure. The signals for the samples diluted 1:1, however, were essentially 
unchanged from those obtained when using the 650°C char.
Figure 13: Peak profile for spiked serum diluted 1:10 using 900°C char
temperature and H N 03-less modifier
An atomization ramp time was added to the temperature program prescribed by 
Pruszkowska, Camrick and Slavin. Samples were diluted 1:1 directly with the acidless 
modifier solution with an increase to 0.5% Triton X-100 in addition to the original 0.2% 
NH4 H2PO4  and 0.05% M g(N03)2 modifiers. Initially, the char temperature o f 650°C was 
used with the atomization temperature of 1700°C; however, the resulting 5 ppb signals 
were split and were very erratic regardless o f the atomization ramp time selected. When 
the 900°C char temperature was tested, however, the results were more decipherable but 
two peaks were always present when an atomization ramp was included in the 
temperature program. Furthermore, as the atomization ramp time was increased, the area 
of the first peak steadily decreased and the second peak steadily appeared earlier in time. 
Figure 14 shows a comparison o f the peak profiles when the sample was atomized at a 
temperature o f 1700°C with a ramp o f one second and with a ramp o f three seconds.
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Once again, there appears to be more than one lead species present with varying 
volatilities after the charring stage.
031
Figure 14: Comparison of profiles for spiked serum diluted 1:1 with an atomization 
ramp of 1 and 3 sec
The signals were then compared to the signal o f an aqueous standard that was 
diluted 1:1 with the same modifier solution (less the Triton X-100) and spiked with lead 
to 5 ppb. It was discovered that the second peak of the serum sample signal closely 
matched the signal profile o f the aqueous standard with respect to time of elution as 
depicted in Figure 15. Thus, it was assumed that the second peak of the serum sample 
signal was representative o f the lead species normally produced, and that the first peak 
was due to a more volatile secondary species produced in the char from unknown 
reactions or interactions.
Figure 15: Aqueous standard with an atomization ramp of 3 seconds
Table 10 contains a summary o f the instrumental parameters and matrix modifiers 
used at this stage o f the investigation. The goal was to further modify the instrumental 
parameters in order to eliminate the first peak while keeping the sample dilution ratio at
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Step Furnace
Temperature
(°C)
Ramp
Time
(s)
Hold
(s)
Internal 
Gas Flow 
(mL/min)
Dry 130 5 45 300
Dry II 260 5 10 300
C har 900 1 5 300
Atomization 1900 3 5 0
Cleanout 2500 1 2 300
Modifier Solution: 0.2%NH4H2PC>4 
0.5% M g(N03)2 
0.5% Triton X-100
Table 10: Revised procedural conditions
As suggested by Granadillo, Navarro and Romero, the slit bandpass through 
which the light sources must pass was reduced from a width of 0.7 nm to a width o f 0.2 
nm in an effort to decrease the background absorption.(23) Because this smaller slit 
width allows less source light to pass through while the electronic noise remains constant, 
it was anticipated that the signals might display more noise than those measured with a 
slit width of 0.7 nm. This was proven to be true. The background signal was reduced a 
bit with the lower 0.2 nm slit width; however, the signals obtained at the 0.7 nm slit width 
were far more reproducible.
The project continued with the use o f a completely different modification solution 
containing 0.5 mg/L Pd and 2% m/v citric acid in 0.01 mol/L nitric acid, as suggested by 
Granadillo, Navarro and Romero.(23) In addition, the purge gas was switched from 
argon to air during the pyrolysis step, in an effort to improve the combustion o f the
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organic matrix. The temperature programs and instrumental parameters prescribed by 
their work were replicated using a bandpass o f 0.7 nm. Precipitation problems were 
anticipated, so the serum samples were diluted 1:10, 1:4 and 1:1 with 0.1% v/v Triton X- 
100 and spiked with lead to 5 ppb. The samples and modifiers were dropped onto the 
platform sequentially instead o f being pre-mixed and dropped onto the platform in one 
shot. For each o f these dilution ratios the signal profiles were similar and double peaks 
were apparent, as seen in Figure 16 for a serum sample diluted 1:9 and modified with the 
0.5 mg/L palladium solution. In order to solve this problem, variations in the atomization 
ramp time were tried for the 1:10 dilutions.
Figure 16: Absorbance profile for 5 ppb serum diluted 1:10, modified with 0.5 mg/L 
Pd and 2% citric acid in 0.01 moI/L H N 03
When an atomization ramp of one second was added to the temperature program, 
the first peak was significantly reduced and the overall peak area was only slightly 
reduced as seen in Figure 17. The two second atomization ramp produced a single peak 
for the samples diluted 1:10; however, the profile appeared later in time and the peak area
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was significantly reduced. Figure 18 shows a comparison of the peak profiles with no 
atomization ramp and with a two second ramp. Finally, the three second atomization 
ramp produced peak profiles for the samples diluted 1:10 that appeared even later than 
those at the two second ramp; however, the profiles were essentially the same shape. The 
three second ramp also eliminated the first peak for the samples diluted 1:4; however, the 
signals were very noisy and not very reproducible.
/
Figure 17: Profile for serum diluted 1:10, using 1 sec atomization ramp
Figure 18: Comparison of profiles using 0 and 2 sec atomization ramp times
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In order to further improve the signal, a greater concentration of palladium was 
added to the modifier. Higher palladium concentrations are typically used for samples 
containing high salt concentrations. Earlier attempts to run samples with Pd 
concentrations in the 0.1-1% range resulted in massive precipitation in the serum 
samples. Thus, a more gradual increase in the Pd levels was investigated.
A new modifier solution containing 5 mg/L Pd and 2% m/v citric acid in 0.01 
mol/L nitric acid was produced. The resulting lead signals from spiked serum samples 
were larger and more reproducible, and the first peak disappeared. However, the high 
background signal was causing the baseline to bottom out. Figure 19 contains a 
comparison of the profiles from 1:4 dilutions using both palladium concentrations; 0.5 
mg/L and 5 mg/L. Higher atomization temperatures of 1800°C and 1900°C were tried in 
an effort to resolve the problem but they produced no appreciable effects.
ri,
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Figure 19: Comparison of profiles for 1:4 using both modifiers,
0.5 mg/L Pd and 5 mg/L Pd
As was expected, when the atomization ramp was altered to two seconds with the 
original atomization temperature o f 2000°C the background signal appeared earlier but
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further attenuated the signal, as seen in Figure 20. When the atomization ramp was
increased to four seconds the background should have appeared later; however, two
background peaks were produced which attenuated the signal early on, as seen in Figure
21. There are apparently numerous species present in the matrix which have significant
temperature dependencies with respect to the time frame associated with volatilization.
Thus, the atomization temperature remained at the recommended 2000°C with a ramp o f
3 seconds for further experimentation with modifiers containing higher palladium
concentrations.
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Figure 20: Peak profile from 2 sec atomization ramp times
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Figure 21: Peak profile from 4 sec atomization ramp times
A modifier solution containing 50 mg/L Pd and 2% citric acid in 0.01 mol/L nitric 
acid was then evaluated. This combination produced signal profiles for the serum 
samples diluted 1:4 that were much more gaussian in peak shape. A comparison o f the 
signals produced using the modifiers containing 5 mg/L Pd and 50 mg/L Pd is shown in 
Figure 22. Note that the signal for the 50 mg/L Pd sample appears longer into the 
atomization time, implying that additional levels o f Pd are stabilizing the Pb species with 
respect to volatilization and atomization temperatures.
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Figure 22: Comparison of signals produced using the modifiers 
containing 5 mg/L Pd and 50 mg/L Pd
In an attempt to further improve the reproducibility and peak profiles, modifier 
solutions containing the 2%  citric acid in 0.01 mol/L nitric acid with various Pd 
concentrations were evaluated. Modifier solutions were prepared containing 100 mg/L 
Pd, 200mg/L Pd, 300 mg/L Pd and 500 mg/L Pd. All modifier concentrations were then 
tested with the furnace conditions prescribed by Granadillo, Navarro and Romero, and 
with the recommended slit bandpass o f 0.2 nm.
The smaller slit width produced signal profiles that were much more noisy, as 
expected. As the lead concentrations in the modifier were increased from 50 mg/L to 500 
mg/L, some signal was lost and the profiles broadened. Figure 23 shows a comparison of 
the signals for 1:4 dilutions with 100 and 300 mg/L Pd in the modifier. At the 500 mg/L 
Pd concentration some background overcompensation was apparent and the signals were 
prematurely quenched. The signals were most reproducible at the middle of the range of 
Pd concentrations, in particular from 100 mg/L to 300 mg/L Pd. For the first time in this
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project, the signals for samples diluted 1:1 were discernible; however, reproducibility 
was very poor. In addition, as the dilution ratio was lessened from 1:4 to 1:1 using the 
same modifier solution, some o f the signal was lost and the samples diluted 1:1 appeared 
later than those diluted 1:4. Figure 24 provides a comparison. It was postulated that 
species in the matrix were decelerating the atomization of the less dilute samples, 
possibly due to increased residues on the graphite surface which provided for poorer 
contact o f the lead at the graphite surface during atomization. Thus, the hold time on the 
char and the atomization temperatures were increased.
Figure 23: Comparison of profiles for samples diluted 1:4, modifiers 
with 100 mg/L Pd and with 300 mg/L Pd
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Figure 24: Comparison of profiles for samples diluted 1:4 and 1:1 using 
modifier with 100 mg/L Pd
Continued improvements in the method from this point made use o f pig and 
human plasma instead o f serum, which is a matrix closer to whole blood less the cell 
content. To ensure that this new matrix did not produce any appreciable differences in 
the signals, the previously tested conditions were used and the signals were essentially 
unchanged. Next, the char ramp was decreased to 15 seconds and the char hold increased 
to 30 seconds using the prescribed char temperature of 600°C. Furthermore, the 
atomization ramp time was increased to 3 seconds, and the hold was increased to 10 
seconds at the prescribed temperature o f 2000°C. The modifier containing 100 mg/L Pd 
was used. Unfortunately, the peak profile was significantly changed and double peaks 
appeared with a quenching apparent between the two. Similar profiles were obtained 
when the atomization temperature was increased to 2100°C and then to 2200°C. When 
the modifier containing 200 mg/L Pd was used, the double peaks persisted and the first 
peak height decreased as the second peak height increased; however, both peak areas
63
appeared to increase as shown in Figure 25. All variations in atomization temperature 
produced similar results, and as the char temperature was increased both peak heights 
decreased. When the Pd concentration in the modifier was increased to 500 mg/L, triple 
peaks appeared and more peaks may have existed after the integration time cut the signal 
off.
Figure 25: Comparison of peak profiles using modifiers with 100 mg/L Pd 
and 200 mg/L Pd
When the originally prescribed conditions were tried again using the modifier 
containing 100 mg/L Pd, the second peak persisted and the profile was essentially the 
same. It was postulated that perhaps an absorptive buildup in the tube was causing the 
additional peaks, and dry fire runs revealed small peaks o f residue. Thus, the hold on the 
cleanout step was increased to five seconds. In addition, runs of just the modifiers 
containing 100 mg/L Pd and 200 mg/L Pd both revealed numerous peaks, and it was 
determined that a lead contamination to the modifiers was contributing to the problem. 
Thus, the graphite tube was changed and new modifiers were produced.
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Experimentation resumed with the temperature program using the increased hold 
times on the char and atomization steps. The temperature program developed to this 
point is summarized in Table 11. The peak profile for the plasma sample diluted 1:4 
using the modifier containing 50 mg/L Pd was clean with only a trace of a second peak. 
The palladium certainly had an impact on the signals; however, because as the Pd 
concentration was increased the second peak began to grow and the first peak began to 
spread out. Figure 26 shows a comparison of the modifiers containing 50 mg/L Pd and 
200 mg/L Pd. It was speculated that as the palladium concentration increased, the chance 
for a matrix-Pd precipitation also increased since Pd significantly enhances precipitation 
o f species in serum and plasma. Thus, the first peak was due to the free Pb, and the 
second was due to some precipitate that required more time to volatilize in the 
atomization stage. In an attempt to prevent precipitation, the order in which the modifier 
and the sample were deposited onto the platform was reversed with the modifier being 
deposited first. This, however, did not produce an appreciable difference in the signal 
profiles.
Step Furnace
Temperature
(°C)
Ramp
Time
(s)
Hold
(s)
Internal 
Gas Flow 
(mL/min)
Dry 120 5 5 300
Dry II 250 20 10 300
Char 600 15 30 300*
Atomization 2000 0 10 0
Cleanout 2700 1 5 300
*Denotes the alternate gas, air.
Table 11: Modified temperature program for use with Pd method
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Figure 26: Comparison of peak profiles using modifiers with 50 mg/L Pd 
and 200 mg/L Pd
At this point in time, the GFAAS system was overhauled. This consisted of a 
thorough cleaning o f the furnace, replacement of the contacts and installation of a new 
graphite tube. When the different modifiers were again compared using the plasma 
diluted 1:4, the second peak again appeared as the concentration of Pd was increased, and 
the first peak again broadened. In addition, a slight attenuation of the signal was detected 
with the growth o f the second peak. The modifier containing 200 mg/L Pd appeared to 
be most reproducible without creating a significant second peak, thus it was used for 
experimentation throughout the remainder o f the project.
As the dilution ratio was lessened from 1:4 to 1:3, the first peak narrowed and the 
second peak again grew; however, the overall peak height remained relatively constant as 
seen in Figure 27. As the samples became less dilute, a lead-containing species was 
being retained longer relative to the majority o f the lead, which was more easily 
volatilized. It was speculated that a small amount of lead might have been imbedded in
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the charred material and thus retained, or the two peaks may have been the result of 
sample splattering during the dry. If  the sample was present in two different areas o f the 
tube, two peaks may have resulted due to temperature variations along the length of the 
tube.
Figure 27: Comparison of peak profiles for plasma diluted 1:4 and 1:3, modifier 
containing 200 mg/L Pd
The temperature program that had been used at this point consisted of two dry 
steps. As the program advanced from one dry to the next, a quiet sizzle was heard. Thus, 
it was determined that sample spattering did in fact contribute to the double peak 
problem. In an attempt to reduce possible sample splattering the first dry temperature 
was increased from 120°C to 150°C with the ramp increased from 5 seconds to 20 
seconds and the hold increased from 5 seconds to 20 seconds. The second dry step was 
eliminated. No spattering was heard with the incorporation of the revised drying 
temperature program. Sample spattering apparently was not the only contributor to the
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double peak problem because the problem worsened with increased Pd concentrations 
and with lower dilution ratios.
The char temperature was next evaluated from 600°C to 1100°C in 100°C 
increments. The second peak height significantly decreased until it eventually 
disappeared as the char temperature was increased. Figure 28 shows a comparison o f the 
profiles for the plasma samples diluted 1:4 using char temperatures of 700°C and 1000°C. 
The revised drying temperature, used in conjunction with the increased char temperature 
o f 1000°C, produced clean signals with comparable peak heights and areas for samples 
diluted as low as 1:3. When these conditions were tried using plasma samples diluted at 
1:2 the second peak reappeared. However, when the char temperature was further 
increased to a temperature o f 1100°C, the second peak disappeared, the signals were 
gaussian and reproducible, and the peak areas and heights were comparable to those of 
the more dilute samples. Figure 29 shows a comparison of the plasma samples diluted 
1:2 using the revised dry conditions and char temperatures o f 1000°C and 1100°C.
Figure 28: Comparison of peak profiles for plasma diluted 1:4 using 
char temperatures of 700°C and 1000°C
Figure 29: Comparison of peak profiles for plasma diluted 1:2 using char 
temperatures of 1000°C and 1100°C
Next, the char temperature was held at 1100°C as the atomization temperature 
varied, in an attempt to optimize the atomization temperature. A slit bandpass o f 0.7 nm 
was used. The plasma samples diluted 1:2 were spiked with lead to 30 ppb, in order to 
increase the signals and facilitate the experimentation. In addition, the signals were 
electronically magnified by a factor o f ten so that additional digits could be evaluated 
when examining signal reproducibility. As the atomization temperature was decreased 
from 2000°C, as was originally prescribed by Granadillo, Navarro and Romero, all the 
way down to an atomization temperature o f 1500°C , the peak areas steadily increased, 
the profiles were essentially unchanged and the reproducibility o f the measurements was 
good. When the atomization temperature was further decreased to 1400°C, the peak 
areas continued to increase but the peak profile spread out across the entire integration 
time. Figure 30 shows for a comparison o f the peak profiles at various atomization 
temperatures with the char held constant at 1100°C. At an atomization temperature o f
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1300°C the signal was significantly decreased, implying that an insufficient temperature 
was obtained to atomize Pb from the sample.
Figure 30: Comparison of profiles for various atomization temperatures with a 
char of 1000°C using plasma diluted 1:2
When these temperature changes were tried with aqueous samples spiked to 30 
ppb the optimum atomization temperature and the peak profiles were markedly different. 
The profiles appeared a little later than those of the plasma samples, the peak heights 
were significantly lower, and the peak areas were lower as well. When the char 
temperature was held constant at 1000°C the peak areas increased as the atomization 
temperature was lowered from 2000°C to 1700°C; however, the peaks broadened and the 
heights decreased. At 1600°C and below the peak areas also began to decrease and a 
small, early-running peak was apparent. Figures 31 and 32 provide profiles for the 
aqueous sample at an atomization temperature of2000°C and 1700°C, respectively. Note 
that the time scaling on the X-axis is different. A plot of peak area vs. atomization 
temperature for blood plasma and aqueous standards is given in Figure 33. The points
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represent the average peak area for the runs done in triplicate. The relative standard 
deviations for these points ranged from 0.64% -3.5% for the plasma; however, the 
relative standard deviation for the point at 1300°C was 20%, as the results were not very 
reproducible at this atomization temperature. The relative standard deviations for the 
aqueous samples ranged from 0.33% to 1.6%, except for the atomization temperature o f 
1400°C. The relative standard deviation at this point was 18.4%, again because the 
results were not very reproducible at this temperature. An interesting result of this study 
was that although the optimum atomization temperatures are significantly different for 
the blood plasma and aqueous standards, the intermediate temperatures of about 1650°C 
and 1800°C provide an overlap where the net absorbance o f both is comparable.
Figure 31: Profile for a 30 ppb aqueous sample with the char at 1100°C and the 
atomization at 2000°C
Figure 32: Profile for a 30 ppb aqueous sample with the char at 1000°C and 
the atomization at 1700°C
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The char temperature was reevaluated using the plasma samples. The atomization 
temperature was held constant at 1500°C, as this temperature produced the best results for 
the plasma. At a char o f 1200°C, a clean gaussian peak was obtained, and numerous 
replicates proved this temperature to be reproducible. As the char temperature was 
decreased to 1100°C the profile was similar and reproducibility was still good. As the 
char temperature was lowered even further, stepwise down to 800°C, the peak areas 
significantly decreased, the background significantly increased, the peak profiles spread 
out and the peaks appeared later with lower reproducibility. Figure 34 shows a 
comparison of these profiles and Figure 35 a graphical interpretation of these results. 
The points represent the average peak area for runs taken in triplicate, and the relative 
standard deviations for these points ranged from 0.23% to 4.6%.
j.
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Figure 34: Comparison of profiles for various char temperatures with an 
atomization of 1500°C using plasma diluted 1:2
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An examination of Figure 33 indicated that at the optimum charring temperature 
o f 1000°C, the peak areas for the plasma samples and aqueous samples should be 
comparable if an atomization temperature o f about 1650°C, 1800°C or 1900°C was used. 
O f these temperatures, 1650°C was closest to the optimal atomization temperature for 
blood plasma (about 1400°C-1500°C). Thus, at an atomization of 1650°C a calibration 
curve could theoretically be generated from aqueous standards which would match 
signals generated from the blood plasma.
The optimized procedural conditions used up to this point are summarized in 
Table 12. A calibration curve was generated from aqueous standards spiked with lead to 
give concentrations o f 5, 15, 30 and 50 ppb. Plasma samples were diluted 1:2 and also 
spiked to the same concentrations. Figure 36 provides a comparison o f the peak profiles 
for both matrices spiked to 30 ppb. The matrix certainly has an effect, as the profiles are 
markedly different. The plasma peak appears first, and the aqueous peak is broader with 
a lower peak height; however, the overall peak areas are essentially the same. Calibration 
curves generated from both matrices are provided in Figure 37. Slopes were generated 
from a linear regression fit using Excel. The slope for the aqueous standards was .0021, 
and that for the plasma samples was .0022. The similarities imply that the matrix effects 
are minimal if peak areas, instead o f peak heights, are considered.
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Step Furnace
Temperature
(°C)
Ramp
Time
(s)
Hold
(s)
Internal
Gas Flow 
(mL/min)
Dry 150 20 20 300
Char 1000 15 30 300*
Atomization 1650 0 5 0
Cleanout 2700 1 5 300
♦Alternate gas, air
Modifier Solution: 200 mg/L Pd and
2% w/v Citric Acid in 
0.01 mol/L Nitric Acid 
Plasma Sample Dilution: 1:2 with 0.1 % v/v Triton X-100
Table 12: Optimized procedural conditions for plasma
3.5TIME ( S E C )
Figure 36: Comparison of peak profiles for both matrices spiked to 30 ppb
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Next, a whole blood sample was diluted 1:2 with 0.1% v/v Triton X-100, spiked 
with lead to 30 ppb and run under the same instrumental parameters. Initially, the blood 
samples did not drop directly onto the L’vov platform but instead climbed up the sides of 
the graphite tube due to high surface tension. Thus, blood samples were diluted with a 
greater concentration o f Triton X-100 surfactant (0.5% v/v). This solved the problem and 
peak profiles were obtained; however, the peak areas were only about 60% of the 
expected value. Thus, the char temperature was increased from 1000°C to 1100°C in an 
effort to increase the signal; however, all signal was lost. Next, a char temperature o f 
1050°C was used and only a hint o f a peak was apparent. When the char temperature was 
lowered to 900°C, the peak areas were equal to those of aqueous standards run with the 
same temperature program.
Using the 900°C char temperature, the peak profiles for the blood samples were 
sharper than those of the plasma samples, and they also appeared earlier in time. In 
addition, the plasma samples gave absorbance peak areas that were erroneously high 
when compared to the signals for the aqueous standards. Figure 38 shows a peak profiles 
for plasma, and Figure 39 shows one for blood. This comparison indicates that the 
organic load has a substantial impact on the lead volatility and atomization rate.
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0
Figure 38: Peak profile for 30 ppb plasma sample diluted 1:2
3 , 0
Figure 39: Peak profile for 30 ppb whole blood sample diluted 1:2
Analytical signals from the blood samples were very reproducible. For five runs 
o f the sample spiked with lead to 30 ppb, an average peak area of 0.0846 A-s was 
obtained with a relative standard deviation o f 4.3%. An unspiked blood sample which 
was run five times gave an average peak area o f 0.0098 A-s with a relative standard 
deviation of 0.92%. Based on Beer’s law, if a signal for 30 ppb gave a reproducible
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average peak area of 0.0846 A-s; a reproducible average peak area o f 0.0098 would 
represent a signal o f about 3.4 ppb. As the unspiked blood samples gave very clean and 
reproducible peak profiles with an average peak area of 0.0098, it can be estimated that 
the limit of detection associated with this method is in the 0.5-1 ppb range. The final 
temperature program and matrix modifiers used to obtain these results are provided in 
Table 13.
Step Furnace
Temperature
(°C)
Ramp
Time
(s)
Hold
(s)
Internal 
Gas Flow 
(mL/min)
Dry 150 20 20 300
Char 900 15 30 300*
Atomization 1650 0 5 0
Cleanout 2700 1 7 300
♦Alternate gas, air
Modifier Solution: 200 mg/L Pd and
2% w/v Citric Acid in 
0.01 mol/L Nitric Acid 
Plasma Sample Dilution: 1:2 with 0.5% v/v Triton X-100
Table 13: Optimized procedural conditions for blood
A calibration curve was generated from aqueous standards spiked with lead to 
give concentrations o f 5,15,30 and 50 ppb. Blood samples were diluted 1:2 with the 
0.5% v/v Triton X-100 and also spiked to the same concentrations. The resulting curves 
are provided in Figure 40. Slopes were again generated from a linear regression fit using 
Excel. The slope for the aqueous standards was 0.0018, and that for the blood samples
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was 0.0010. Although the aqueous curve is a little higher than the blood curve, the 
similarities again imply that the matrix effects are insignificant if peak area, instead of 
peak heights, are considered. Time did not allow for further refinements in the method.
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An explanation for this difference in the peak profiles can be derived from an 
explanation o f the atomization mechanism postulated by Granadillo, Navarro and 
Romero.(23) The mechanisms by which palladium actually interacts with the lead 
analyte are still being debated. However, it is apparent that any model intended to 
elucidate the atomization mechanism must consider the following circumstances: (1) the 
type o f chemical and/or physical interactions existing between the graphite surface, the 
analytical matrix modifier and the analyte; (2) the reductive capability o f the carbon at 
the high operating temperatures o f the ETAAS technique; and (3) the availability o f 
active carbons within the graphite furnace to reduce the atomic precursor to the analyte 
atoms. Thus, Granadillo, Navarro and Romero considered the effects that increasing 
amounts of potentially reducing carbon, produced by the addition of carbon-containing 
compounds to the samples, exerted on the absorbance-time profiles of lead atomized in 
the graphite furnace. In addition, the reductive action o f the carbon in the graphite 
furnace itself was considered.
Several researchers have established that the graphite surface plays a major role 
in the atomization of any metal in GFAAS.(12,16,17) The graphite surface consists o f 
crystallites o f graphite with carbon atoms lying in a basal plane which is terminated by 
carbons in zigzag and armchair configurations.(23) These edge carbons constitute the 
active surface area o f the graphite because they have unpaired a-electrons available to 
form bonds, whereas the basal plane carbons have their a-electrons tied up in bonds with 
the adjacent carbons.
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Previous work has indicated that the use o f reducing agents to promote the 
reduction o f palladium is essential to obtain the modification effect.(23) In this study, the 
citric acid was utilized for this purpose to create a better reducing environment by 
providing active carbon sites different from those found on the graphite furnace. Thus, in 
the presence o f the citric acid, the carbon sites of the furnace were less susceptible to 
oxidation and the lifetime o f the graphite structure was prolonged.
When no citric acid was added to either the aqueous or blood samples they 
discovered that the fastest lead atomization occurred in the blood samples due to the high 
organic content.(23) Apparently, an additional supply o f reducing carbons, different 
from those provided by the graphite furnace, were available from the carbonaceous 
matrix. However, when 200 pg o f citric acid was added to both the aqueous and blood 
samples, the lead profiles appeared at the same early time. Furthermore, this 
phenomenon occurred with the exact same profile appearance time for both the palladium 
modification solution and also for a phosphate-magnesium modification solution.
These results suggested that the atomization rate o f lead was independent o f the 
matrix and of the modifier used, and that a carbon-dependent mechanism occurred.(23) 
The differences in the plasma and blood peak profiles provided in Figures 38 and 39 
added further credence to this theory. The blood samples, which contained a higher 
carbonaceous load, appeared much earlier than the plasma samples.
Granadillo, Navarro and Romero proposed the following mechanisms for the 
atomization of lead by GFAAS with palladium modification [equations (1) and (2)] and
85
with magnesium-phosphate modification [equations (3) through (5)], assuming that a 
carbon source other than the graphite surface was available.(23)
*-Pd-PbO —► PbO (1)
PbO + C Pb + CO (2)
and
*-Pb2P20 7 -► Pb2P20 7 (3)
Pb2P20 7 + 2C P20 3 + 2PbO + 2CO (4)
2PbO + 2C -> 2Pb + 2CO (5)
* denotes carbon surface of graphite tube
The intermediate species, such as PbO and Pb2P20 7, were not identified in this 
study due to a lack of instrumental facilities; however, further experimentation added 
credence to the postulated atomization mechanism.(23) The redox reaction between 
Pb2P20 7 and 2 mol o f carbon atoms, as postulated, would result in the formation o f 1 mol 
of P20 3, 2 mol o f PbO and 2 mol o f CO. A further 2 mol o f carbon would then be 
required for the reduction o f the 2 mol o f PbO to form 2 mol of Pb atoms and 2 mol of 
CO. Therefore, 4 mol o f carbon atoms would be needed for the over-all reaction if it
occurred as written. This was verified experimentally when four times more mass of
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citric acid was needed to reduce the phosphate-magnesium modification than for the 
palladium modification technique, with the same appearance time for the analyses o f the 
samples and aqueous standards.
Additional support for the proposed mechanism was obtained when atomization 
was attempted under a partial pressure of CO, and it was discovered that the absorbance 
profiles for both standards and samples appeared later in time.(23) It was postulated that 
the time shift in the appearance o f the absorption pulse occurred as a result o f a 
suppression o f the redox reaction that produced atomic lead, as described by equation (2), 
in response to the increase in the partial pressure o f CO. The carbon monoxide 
atmosphere caused the system at equilibrium to shift to the reactant side.
In conclusion, the proposed carbon-induced reduction o f the atomic precursor 
may be the mechanism to occur for any analyte that undergoes atomization via the 
oxide.(23) However experimental verification, such as by GFAAS-mass spectrometry, o f 
the existence of the postulated intermediates in the graphite furnace is required to further 
substantiate this atomization mechanism o f lead.
Chapter VI: Summary
The use o f GFAAS for the determination o f lead in blood has increased 
significantly in the past decade.(18) Most o f the published methods utilize the Zeeman 
background correction system; however, this system is not readily available in many 
testing laboratories and the methodology utilized was found not to be effective with a 
more conventional deuterium arc background correction system. This led to the 
development o f refined matrix modification and atomization procedures which gave a 
good reproducibility and sensitivity, and also a good linear range o f determination for 
lead in blood. The limits o f detection in particular were significantly improved by a 
factor o f about ten over values reported in the literature by reducing the dilution ratio 
necessary for the blood analysis.
Work with whole blood samples was only performed over the very last stages of 
this project, thus there are several parameters that need to be addressed and refined. In 
particular, an optimization o f the furnace and temperature conditions such that all signals 
are equivalent regardless o f whether the samples are aqueous, plasma or whole blood 
would be very beneficial. In addition, further verification of the reproducibility needs to 
be addressed in particular with the whole blood samples at low concentrations (<10 ppb).
87
88
Finally, the complete linear working range for lead concentrations in blood must be 
determined.
Reproduciblity will be a crucial consideration based on the CDC requirement that 
clinical decisions be made for children whose blood Pb level is above 150 ppb. For 
instance, suppose a physician is monitoring a child whose true BPb is at a dangerous 
level o f 170 ppb. The blood analyses at two laboratories both work with reproducibilities 
within an accepted + or -  20 ppb limit. The physician may face a situation where one 
laboratory returns a result o f 150 ppb, which may not require intervention, and the other 
returns a 190 ppb result, which would require intervention. Clearly, the burden on public 
health officials would be lessened if laboratories could operate within a +/- 1-5 ppb limit 
at low levels. The method described by this work appears to have good reproducibility as 
referenced by the relative standard deviation of 4.3% for 30 ppb blood samples. This 
standard deviation is clearly reproducible enough to give good clinical reliability; 
however, continued refinements to the methodology may be necessary for accurate 
quantification and use in large scale screening programs.
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